Adjuvants are not active ingredients for the purposes of SPC protection
The Court of Justice of the European Union (CJEU) has released a ‘reasoned order’ in the GSK Biologicals SA case (C-210/13). The conclusion is that an adjuvant to a vaccine is not an active ingredient and so a vaccine/adjuvant combination is not a product capable of SPC protection…
If you are registered and logged in to the site, click on the link below to read the rest of the Taylor Wessing briefing. If not, please register or sign in with your details below.
News from Taylor Wessing
News from The Lawyer
Briefings from Taylor Wessing
Insolvency proceedings were opened in respect of the assets of a German resident; the liquidator then sought to set aside a transaction that had been entered into with a resident of Switzerland.
As of 1 October 2012, transfers of majority shares in a private limited liability company in Slovakia have become more complicated.
Analysis from The Lawyer
The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world
Financial disputes are starting to dominate the English courts as the long-awaited fallout from the downturn finally comes to town